These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6156880)

  • 1. Effects of dextran sulphate and flufenamic acid on euglobulin fibrinolytic activity of glass-treated or heated plasma.
    Jenks RL; Astrup T
    Haemostasis; 1980; 9(4):248-56. PubMed ID: 6156880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of fibrinolytic activity in bovine plasma by the combined effects of chloroform and dextran sulphate.
    Jenks RL; Kluft C; Astrup T
    Haemostasis; 1981; 10(2):108-18. PubMed ID: 6161866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of inhibition in euglobulin fibrinolysis by use of flufenamate: involvement of C1-inactivator.
    Kluft C
    Haemostasis; 1977; 6(6):351-69. PubMed ID: 611048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
    Matsuo O; Kawaguchi T; Kosugi T; Mihara H
    Thromb Res; 1978 Dec; 13(6):1125-30. PubMed ID: 749265
    [No Abstract]   [Full Text] [Related]  

  • 6. Dextran sulfate-dependent fibrinolysis in whole human plasma.
    Miles LA; Rothschild Z; Griffin JH
    J Lab Clin Med; 1983 Feb; 101(2):214-25. PubMed ID: 6185600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
    Gram J; Jespersen J; Astrup T
    Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of euglobulin methods for the study of blood fibrinolytic activity: results for patients with rheumatoid arthritis and in the postoperative period.
    Kluft C; Cooper P; Jie AF; Lowe GD; Forbes CD; Blamey SL; van de Putte LB
    Haemostasis; 1985; 15(2):144-50. PubMed ID: 3874124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of C1 inactivator and other proteinase inhibitors in euglobulin fractions and their influence on fibrinolytic activity.
    Kluft C
    Haemostasis; 1976; 5(3):136-46. PubMed ID: 12071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C1-inactivator-resistant fibrinolytic activity in plasma euglobulin fractions: its relation to vascular activator in blood and its role in euglobulin fibrinolysis.
    Kluft C
    Thromb Res; 1978 Aug; 13(2):135-51. PubMed ID: 694838
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic activity of salivary euglobulin fractions precipitated at pH 5.9 or 6.4 before and after mixing with blood.
    Gersel-Pedersen N
    Int J Oral Surg; 1980 Jun; 9(3):190-7. PubMed ID: 6777318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
    Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
    Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity.
    Jespersen J
    Thromb Haemost; 1986 Oct; 56(2):183-8. PubMed ID: 3101221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay characteristics and fibrin affinity of plasminogen activators of the intrinsic fibrinolytic system.
    Kok P; Nilsson T
    Thromb Res; 1986 Jan; 41(2):197-209. PubMed ID: 2421431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the activation mechanism of fibrinolysis by dextran sulphate].
    Mihara H; Ichihashi M; Okamoto S
    Nihon Seirigaku Zasshi; 1970 Jan; 32(1):25-34. PubMed ID: 5462228
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of evacuated glass tubes for collection of blood samples for fibrinolytic assays.
    Jespersen J; Knudsen LH; Sidelmann J
    Thromb Res; 1982 Jan 1-15; 25(1-2):173-6. PubMed ID: 7064131
    [No Abstract]   [Full Text] [Related]  

  • 17. Euglobulin lysis time in fresh and stored samples.
    Prisco D; Paniccia R; Bandinelli B; Filippini M; Brunelli T; Zarone N; Francalanci I; Abbate R
    Am J Clin Pathol; 1994 Dec; 102(6):794-6. PubMed ID: 7801893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The euglobulin clot lysis time, a rapid and sensitive method for the assay of fibrinolytic activity after venous stasis.
    Nordby E; Arnesen H; Andersen P; Godal HC
    Scand J Haematol; 1980 Nov; 25(5):407-11. PubMed ID: 7221476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.